Modulation of the Dinucleotide Receptor Present in Rat Midbrain Synaptosomes by Adenosine and ATP

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2000 May 12

PMID 10807683

Citations 9

Authors

M Diaz-Hernandez

J Pintor

M T Miras-Portugal

Affiliations

Soon will be listed here.

Abstract

Diadenosine polyphosphates activate dinucleotide receptors in rat midbrain synaptic terminals. The agonist with highest affinity at this receptor, diadenosine pentaphosphate (Ap(5)A), elicits Ca(2+) transients at concentrations ranging from 10(-7) to 10(-3) M with a single-phase curve and an EC(50) value of 56.21+/-1.82 microM. Treatment of synaptosomal preparations with alkaline phosphatase (AP) changes the dose-response control curve into a biphasic one presenting two EC(50) values of 6.47+/-1.25 nM and 11.16+/-0.83 microM respectively. The adenosine A(1) antagonist 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX) reversed the biphasic concentration-response for Ap(5)A curve in the presence of AP, to a monophasic one with an EC(50) value of 76.05+/-7.51 microM. The application of adenosine deaminase produced the same effect as DPCPX, the EC(50) value for Ap(5)A, in the presence of AP being 18.62+/-4.03 microM. Activation of the adenosine A(1) receptor by means of cyclohexyladenosine (CHA) shifted the dose response curve for Ap(5)A to the left, resulting in a monophasic curve with an EC(50) of 5. 01+/-0.02 pM. The destruction of extrasynaptosomal nucleotides by AP or the addition of pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS), a broad P2 antagonist compound, enhance maximal effect of the Ap(5)A up to 55.6% on the dose response curve, thus suggesting a negative modulation by P2 receptors. In a summary, ATP and adenosine present at the extra-synaptosomal space, are relevant natural modulators of the dinucleotide receptor, via P2 and adenosine A(1) receptors respectively.

Citing Articles

Alteration of Vascular Responsiveness to Uridine Adenosine Tetraphosphate in Aortas Isolated from Male Diabetic Otsuka Long-Evans Tokushima Fatty Rats: The Involvement of Prostanoids.

Matsumoto T, Kobayashi S, Ando M, Iguchi M, Takayanagi K, Kojima M Int J Mol Sci. 2017; 18(11).

PMID: 29120387 PMC: 5713347. DOI: 10.3390/ijms18112378.

Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation.

Sebastian-Serrano A, Engel T, de Diego-Garcia L, Olivos-Ore L, Arribas-Blazquez M, Martinez-Frailes C Hum Mol Genet. 2016; 25(19):4143-4156.

PMID: 27466191 PMC: 5291194. DOI: 10.1093/hmg/ddw248.

Tissue-nonspecific Alkaline Phosphatase Regulates Purinergic Transmission in the Central Nervous System During Development and Disease.

Sebastian-Serrano A, de Diego-Garcia L, Martinez-Frailes C, Avila J, Zimmermann H, Millan J Comput Struct Biotechnol J. 2015; 13:95-100.

PMID: 25709758 PMC: 4334957. DOI: 10.1016/j.csbj.2014.12.004.

Presence of diadenosine polyphosphates in microdialysis samples from rat cerebellum in vivo: effect of mild hyperammonemia on their receptors.

Gualix J, Gomez-Villafuertes R, Pintor J, Llansola M, Felipo V, Miras-Portugal M Purinergic Signal. 2013; 10(2):349-56.

PMID: 23943472 PMC: 4040178. DOI: 10.1007/s11302-013-9382-3.

Tissue-nonspecific alkaline phosphatase promotes axonal growth of hippocampal neurons.

Diez-Zaera M, Diaz-Hernandez J, Hernandez-Alvarez E, Zimmermann H, Diaz-Hernandez M, Miras-Portugal M Mol Biol Cell. 2011; 22(7):1014-24.

PMID: 21289095 PMC: 3069005. DOI: 10.1091/mbc.E10-09-0740.

References

Gualix J, Fideu M, Pintor J, Rotllan P, Garcia-Carmona F, Miras-Portugal M . Characterization of diadenosine polyphosphate transport into chromaffin granules from adrenal medulla. FASEB J. 1997; 11(12):981-90. DOI: 10.1096/fasebj.11.12.9337151. View

Pintor J, Gualix J, Miras-Portugal M . Dinucleotide receptor modulation by protein kinases (protein kinases A and C) and protein phosphatases in rat brain synaptic terminals. J Neurochem. 1997; 68(6):2552-7. DOI: 10.1046/j.1471-4159.1997.68062552.x. View

Potter P, White T . Release of adenosine 5'-triphosphate from synaptosomes from different regions of rat brain. Neuroscience. 1980; 5(7):1351-6. DOI: 10.1016/0306-4522(80)90207-9. View

Stone T, Perkins M . Adenine dinucleotide effects on rat cortical neurones. Brain Res. 1981; 229(1):241-5. DOI: 10.1016/0006-8993(81)90764-2. View

Grynkiewicz G, Poenie M, Tsien R . A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985; 260(6):3440-50. View

Fastbom J, Fredholm B . Effects of long-term theophylline treatment on adenosine A1-receptors in rat brain: autoradiographic evidence for increased receptor number and altered coupling to G-proteins. Brain Res. 1990; 507(2):195-9. DOI: 10.1016/0006-8993(90)90272-d. View

Hoyle C . Pharmacological activity of adenine dinucleotides in the periphery: possible receptor classes and transmitter function. Gen Pharmacol. 1990; 21(6):827-31. DOI: 10.1016/0306-3623(90)90440-w. View

Linden J . Structure and function of A1 adenosine receptors. FASEB J. 1991; 5(12):2668-76. DOI: 10.1096/fasebj.5.12.1916091. View

Pintor J, Torres M, Miras-Portugal M . Presence of diadenosine polyphosphates--Ap4A and Ap5A--in rat brain synaptic terminals. Ca2+ dependent release evoked by 4-aminopyridine and veratridine. Neurosci Lett. 1992; 136(2):141-4. DOI: 10.1016/0304-3940(92)90034-5. View

10.

Barrie A, Nicholls D . Adenosine A1 receptor inhibition of glutamate exocytosis and protein kinase C-mediated decoupling. J Neurochem. 1993; 60(3):1081-6. DOI: 10.1111/j.1471-4159.1993.tb03257.x. View

11.

Yawo H, Chuhma N . Preferential inhibition of omega-conotoxin-sensitive presynaptic Ca2+ channels by adenosine autoreceptors. Nature. 1993; 365(6443):256-8. DOI: 10.1038/365256a0. View

12.

Ziganshin A, Hoyle C, Bo X, Lambrecht G, Mutschler E, Baumert H . PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br J Pharmacol. 1993; 110(4):1491-5. PMC: 2175839. DOI: 10.1111/j.1476-5381.1993.tb13990.x. View

13.

Klishin A, Lozovaya N, Pintor J, Miras-Portugal M, Krishtal O . Possible functional role of diadenosine polyphosphates: negative feedback for excitation in hippocampus. Neuroscience. 1994; 58(2):235-6. DOI: 10.1016/0306-4522(94)90030-2. View

14.

Wu L, Saggau P . Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron. 1994; 12(5):1139-48. DOI: 10.1016/0896-6273(94)90321-2. View

15.

Fredholm B, Abbracchio M, Burnstock G, Daly J, Harden T, Jacobson K . Nomenclature and classification of purinoceptors. Pharmacol Rev. 1994; 46(2):143-56. PMC: 4976594. View

16.

Fideu M, Arce A, Esquifino A, Miras-Portugal M . Thyroid hormones modulate both adenosine transport and adenosine A1 receptors in rat brain. Am J Physiol. 1994; 267(6 Pt 1):C1651-6. DOI: 10.1152/ajpcell.1994.267.6.C1651. View

17.

Baxi M, Vishwanatha J . Diadenosine polyphosphates: their biological and pharmacological significance. J Pharmacol Toxicol Methods. 1995; 33(3):121-8. DOI: 10.1016/1056-8719(94)00127-p. View

18.

Pintor J, Miras-Portugal M . P2 purinergic receptors for diadenosine polyphosphates in the nervous system. Gen Pharmacol. 1995; 26(2):229-35. DOI: 10.1016/0306-3623(94)00182-m. View

19.

Pintor J, Miras-Portugal M . A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes. Br J Pharmacol. 1995; 115(6):895-902. PMC: 1909007. DOI: 10.1111/j.1476-5381.1995.tb15894.x. View

20.

Ribeiro J . Purinergic inhibition of neurotransmitter release in the central nervous system. Pharmacol Toxicol. 1995; 77(5):299-305. DOI: 10.1111/j.1600-0773.1995.tb01031.x. View